louisiana glp-1 gastric intestinal obstruction lawsuit in Victoza Lawsuit [2026 Update] Ozempic Lawsuit [2026 Update]

This analysis does not rank products, endorse outcomes, or predict results

In the Danish registry-based cohort, dementia risk was reduced 11% (HR = 0.89) with yearly increased exposure to GLP-1 RAs

A 2023 study of more than 17,000 patients published in the New England Journal of Medicine found that semaglutide reduced the risk of major cardiovascular events including heart attack, stroke and cardiovascular death by about 20% in overweight or obese adults who already have cardiovascular disease but not diabetes

Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: myth or truth

The FDA has not evaluated these compounded medications for safety, quality, or efficacy